What Is GS-441524, the New Drug for Feline FIP? — Key Points to Know Before Treatment

ImmunityQ&AMeongsiljang Veterinary Advisory Board

We’ve compiled everything pet owners need to know about GS-441524, a treatment for feline infectious peritonitis (FIP), including its mechanism of action, administration methods, costs, and potential side effects.

What Is GS-441524?

GS-441524 is an antiviral ingredient used to treat feline infectious peritonitis (FIP). In the past, textbooks described FIP as almost invariably fatal in both its effusive and non-effusive forms, with a rapid progression leading to death within a short period of one week to as long as six months after onset. Therefore, it is crucial to prepare for treatment without delay once a definitive diagnosis is made. Although the prognosis for this disease was once bleak, the introduction of antiviral therapy has significantly changed expectations for treatment, as studies have consistently reported cases of cats achieving long-term survival beyond 200 and 300 days.

What Kind of Disease Is FIP?

Feline infectious peritonitis (FIP) is a fatal disease caused by a mutation of the feline coronavirus that leads to widespread inflammation of the blood vessels. According to veterinary internal medicine textbooks, it is classified into two types: effusive (characterized by fluid accumulation in the abdomen or chest) and non-effusive (characterized by granuloma formation in organs). - Effusive (Wet form): Yellowish fluid accumulates in the abdomen or chest, causing abdominal distension and labored breathing. - Non-effusive (Dry form): Inflammatory masses develop in the liver, kidneys, eyes, or brain, with a slow progression. It particularly affects young cats under two years of age.

How Does GS-441524 Work?

GS-441524 is a nucleoside analog that directly blocks viral RNA replication. In simpler terms, it’s an ingredient that prevents the virus from replicating within the body. Early clinical studies have reported cases of FIP cats treated with GS-441524 achieving long-term survival for several months or more, and positive treatment outcomes are accumulating. Even in neurological FIP cases involving the brain and eyes, one report confirmed clinical improvement and long-term remission when treated for at least 12 weeks at an appropriate dose (approximately 5–10 mg/kg, once daily via subcutaneous injection).

The mechanism by which GS-441524 blocks viral replication

Recommended GS-441524 Dosage by FIP Type

Item	Dose reported in studies	Treatment duration	Characteristics
Effusive form (ascites/pleural effusion)	5–10 mg/kg, once daily (study-reported range)	Minimum 12 weeks (84 days)	A form in which effusion fluid accumulates in the abdominal·thoracic cavity
Non-effusive form (organ form)	5–10 mg/kg, once daily (study-reported range)	Minimum 12 weeks (84 days)	A form in which granulomatous inflammation develops in organs
Ocular form	5–10 mg/kg, once daily (study-reported range)	Minimum 12 weeks (84 days)	Ocular changes most commonly appear in the non-effusive form
Neurological form (brain)	5–10 mg/kg, once daily (study-reported range)	Minimum 12 weeks or more	Accompanied by central nervous symptoms such as seizures·ataxia

Per textbook evidence, the reported dose ranges are similar regardless of type, and the exact mg/kg dose and treatment duration are determined by the veterinarian based on body weight and symptoms. Adjusting on your own can leave viral suppression incomplete.

Essential Principles to Follow During Administration

Studies have shown that GS-441524 should be administered daily without missing any doses for at least 12 weeks (84 days), so it is important to strictly follow the prescribed dosing schedule. Interrupting or stopping treatment arbitrarily can lead to incomplete viral suppression and reduced therapeutic efficacy. Do not discontinue medication on your own, even if symptoms appear to have noticeably improved. Always consult your veterinarian before making any changes to the dosing method or duration.

Injectable vs. Oral Form: What’s the Difference?

GS-441524 is available in two forms: injectable (subcutaneous) and oral (tablets or liquid). - Injectable form: Administered daily via subcutaneous injection, requiring consistent care from the pet owner. It is important to rotate the injection site regularly. - Oral form: This option involves less handling stress and causes no pain. The use of oral adenosine nucleoside formulations has been reported for conditions such as ocular lesions in non-effusive FIP. Your veterinarian will determine which form is most appropriate by comprehensively evaluating your cat’s condition, body weight, and compliance with medication administration.

Comparison of GS-441524 injectable and oral formulations

Side Effects and Monitoring Points

Since GS-441524 is an antiviral medication, it is essential to consistently monitor your cat’s condition throughout treatment. - Injection site care: Because the medication is administered via daily subcutaneous injection, it is important to rotate injection sites regularly and carefully check the skin for any issues. - Systemic health monitoring: Keep a daily log of your cat’s activity level, appetite, and weight changes, and contact your veterinarian immediately if you notice any abnormalities. - Regular blood tests: Perform blood tests at intervals specified by your veterinarian to monitor changes in major organ function and blood cell counts. - Unexpected reactions: Individual responses to the medication can vary, so report any unusual symptoms to your veterinarian right away. Monitoring through regular check-ups is key to successful treatment.

Observation Period After Treatment Completion

Even after the 84-day course of medication is completed, a sufficient observation period is necessary to confirm whether the condition recurs. If symptoms reappear during this time, you should immediately consult your veterinarian to begin retreatment. If the observation period passes without any issues, the cat can be considered clinically cured. Improvements in clinical signs and behavioral indicators have been reported in cats that have achieved long-term survival, and a positive prognosis can be expected for those who successfully complete treatment.

How to Purchase in Korea and Costs

Although GS-441524 is not officially approved as a veterinary drug in Korea, some animal hospitals offer it through imported prescriptions. Treatment protocols and costs vary by clinic, so be sure to choose a hospital with extensive experience in treating FIP. Treatment costs vary significantly depending on the cat’s weight, the type of FIP, and the route of administration (injection or oral). When consulting about treatment, ask for the total estimated cost for the full 84-day protocol, including blood test fees.

A pet owner and veterinarian discussing FIP treatment options

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

My cat has been diagnosed with FIP. Can we start GS-441524 treatment right away?

If the diagnosis is confirmed, it’s best to start treatment without delay. However, FIP is difficult to confirm with antibody testing alone, as it only indicates exposure to coronavirus. Accurate diagnosis requires a comprehensive evaluation including abdominal fluid analysis, blood tests, and PCR testing. Therefore, treatment should only begin after a veterinarian has made a definitive diagnosis.

The symptoms improved midway through treatment, and giving the injections has become very difficult. Is it okay to stop them early?

Absolutely not. Failing to follow the 84-day protocol increases the risk of relapse. If the injections are too difficult, consult your veterinarian about switching to an oral medication.

Can it be transmitted to other cats?

FIP itself is not contagious. While the coronavirus can spread, the mutation that leads to FIP occurs on an individual basis. Even in multi-cat households, isolation is not necessary.

What is the recurrence rate after treatment?

Results vary across studies, so it’s difficult to pinpoint an exact recurrence rate based on current evidence alone. However, strictly following the treatment protocol is key to reducing the risk of recurrence. If the condition does return, you can consult with your veterinarian to discuss the possibility of additional treatment.

Is there a preventive vaccine available?

The evidence supporting FIP preventive vaccines remains limited to date. The most effective prevention strategy is to reduce exposure to feline coronavirus, with key measures including minimizing stress in young cats, avoiding overcrowded living conditions, and maintaining strict fecal hygiene through regular litter box cleaning.

Primary vs. Secondary Veterinary Hospitals: A Comparison

Comparing Dog Vaccine Types (3-way, 5-way, 7-way): Differences and How to Choose

Pet Insurance Enrollment Timing Comparison: When Is the Most Advantageous Time to Enroll?

Is homemade dog food safe? — Prohibited ingredients to remove and how to balance nutrition

Guide to Using Secondary Veterinary Hospitals (Referral Hospitals): When to Visit and How to Prepare

Guide to Using Canine Dermatology Specialty Services

What Is Feline Restrictive Cardiomyopathy (RCM)? — From Symptoms to Management Timing

Canine Osteoarthritis: Symptoms and Management

What Is Hemophilia in Dogs? — Warning Signs of Bruising and Bleeding, and Lifelong Management

Why Does High Blood Pressure Occur in Dogs? — A Comprehensive Guide from Symptoms to Daily Management

References

[1] Pedersen NC et al., Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis, Journal of Feline Medicine and Surgery, 2019

[2] Clinical Medicine of the Dog and Cat, 4th Edition — Feline Infectious Peritonitis Chapter

[3] The Cat, Clinical Medicine and Management, 2nd Edition — FIP Diagnosis and Treatment

[4] Dickinson PJ et al., Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological FIP, Journal of Veterinary Internal Medicine, 2020